ArticleDrug testing and analysis2026
Evaluation of Therapeutic Opioids in Skin-Derived Matrices (Sweat and Sebum) of Neonatal and Pediatric Patients and Their Role in Opioid Incorporation Into Hair.
Article in Drug testing and analysis, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Hair analysis is a valuable tool in forensic toxicology to assess opioid exposure in both adult and pediatric populations. However, interpretation of analysis results is challenged by the scarcity of reliable reference data on opioids in hair and by the lack of knowledge on involved hair incorporation pathways, e.g., via skin-derived matrices such as sweat and sebum. In order to address these limitations, we conducted a clinical study in cooperation with the University Children's Hospital Zurich, where we obtained and analyzed hair and skin swab samples of 150 pediatric intensive-care patients (median age: 53 days). These patients had a treatment history with opioids, including fentanyl, sufentanil, remifentanil, alfentanil, morphine, methadone, and hydromorphone. Most of the substances, as well as selected metabolites, were repeatedly detected in both sample types, exhibiting comparable concentration trends and metabolite-to-parent drug ratios. For fentanyl and morphine, a positive correlation was observed between the administered opioid doses and the analyte concentrations in both the hair and skin swab samples. In addition, a correlation was found for fentanyl between concentrations in hair and skin swab samples (r = 0.356, p = 0.0007), indicating a contribution of skin-derived matrices to opioid incorporation into the hair of children and neonates. The comprehensive and clinical nature of this study provides unique value for the generated concentration data and associated findings, providing a potential reference source for future interpretation of hair analysis results.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.